BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruzza C, Calò G, Di Maro S, Pacifico S, Trapella C, Salvadori S, Preti D, Guerrini R. Neuropeptide S receptor ligands: a patent review (2005-2016). Expert Opin Ther Pat 2017;27:347-62. [PMID: 27788040 DOI: 10.1080/13543776.2017.1254195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED Jr, Gavioli EC. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel) 2021;14:775. [PMID: 34451872 DOI: 10.3390/ph14080775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Reinscheid RK, Ruzza C. Pharmacology, Physiology and Genetics of the Neuropeptide S System. Pharmaceuticals (Basel) 2021;14:401. [PMID: 33922620 DOI: 10.3390/ph14050401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
3 Albanese V, Ruzza C, Marzola E, Bernardi T, Fabbri M, Fantinati A, Trapella C, Reinscheid RK, Ferrari F, Sturaro C, Calò G, Amendola G, Cosconati S, Pacifico S, Guerrini R, Preti D. Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity. J Med Chem 2021;64:4089-108. [PMID: 33733768 DOI: 10.1021/acs.jmedchem.0c02223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Batran RZ, Gugnani KS, Maher TJ, Khedr MA. New quinolone derivatives as neuropeptide S receptor antagonists: Design, synthesis, homology modeling, dynamic simulations and modulation of Gq/Gs signaling pathways. Bioorg Chem 2021;111:104817. [PMID: 33848721 DOI: 10.1016/j.bioorg.2021.104817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Holanda VAD, Oliveira MC, Souza LS, Lobão-Soares B, André E, Da Silva Junior ED, Guerrini R, Calo G, Ruzza C, Gavioli EC. Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test. Eur J Pharmacol 2019;859:172557. [PMID: 31326375 DOI: 10.1016/j.ejphar.2019.172557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang ZR, Tao YX. Physiology, pharmacology, and pathophysiology of neuropeptide S receptor. Prog Mol Biol Transl Sci 2019;161:125-48. [PMID: 30711025 DOI: 10.1016/bs.pmbts.2018.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ruzza C, Ferrari F, Guerrini R, Marzola E, Preti D, Reinscheid RK, Calo G. Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies. Pharmacol Res Perspect 2018;6:e00445. [PMID: 30534379 DOI: 10.1002/prp2.445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 He Q, Shen Z, Ren L, Wang X, Qian M, Zhu J, Shen X. Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder. Biochem Biophys Res Commun 2018;504:137-42. [PMID: 30190127 DOI: 10.1016/j.bbrc.2018.08.145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Batran RZ, Dawood DH, El-seginy SA, Maher TJ, Gugnani KS, Rondon-ortiz AN. Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking. Bioorganic Chemistry 2017;75:274-90. [DOI: 10.1016/j.bioorg.2017.09.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
10 Jinushi K, Kushikata T, Kudo T, Calo G, Guerrini R, Hirota K. Central noradrenergic activity affects analgesic effect of Neuropeptide S. J Anesth 2018;32:48-53. [PMID: 29128909 DOI: 10.1007/s00540-017-2427-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Calo' G, Rizzi A, Ruzza C, Ferrari F, Pacifico S, Gavioli EC, Salvadori S, Guerrini R. Peptide welding technology - A simple strategy for generating innovative ligands for G protein coupled receptors. Peptides 2018;99:195-204. [PMID: 29031796 DOI: 10.1016/j.peptides.2017.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
12 Liu X, Si W, Garau C, Jüngling K, Pape HC, Schulz S, Reinscheid RK. Neuropeptide S precursor knockout mice display memory and arousal deficits. Eur J Neurosci 2017;46:1689-700. [PMID: 28548278 DOI: 10.1111/ejn.13613] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]